Do antihistamines help atopic dermatitis?

• by Kathryn Wighton

• August 31, 2026

FDA Approves Less Frequent Lebrikizumab Dosing

Approval adds an every-8-week maintenance option for eligible patients with moderate-to-severe atopic dermatitis.

• by Kathryn Wighton

• June 10, 2026

• 2 min

Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)

• by Emma Guttman-Yassky, Alan D. Irvine, Melinda Gooderham, Stephan Weidinger, Lynda Spelman, Jonathan I. Silverberg, Heidi Crane, Hany ElMaraghy, Louise DeLuca-Carter, Maria Lucia Buziqui Piruzeli, Georgia Martimianaki, Evangeline Pierce, Helena Agell, Diamant Thaçi

• June 19, 2026

Earlier Egg Intake Linked to Less Allergy

Population-based data suggest uptake of updated feeding recommendations coincided with modest declines in egg allergy prevalence, particularly among infants with early eczema.

• by Andrea Surnit

• June 17, 2026

• 4 min